Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Camptothecin / administration & dosage
• Camptothecin / adverse effects
• Camptothecin / analogs & derivatives
• Carcinoma, Pancreatic Ductal / drug therapy*
• Carcinoma, Pancreatic Ductal / mortality
• Disease-Free Survival
• Fluorouracil / administration & dosage
• Fluorouracil / adverse effects
• Humans
• Irinotecan
• Kaplan-Meier Estimate
• Leucovorin / administration & dosage
• Leucovorin / adverse effects
• Neoadjuvant Therapy / adverse effects
• Neoadjuvant Therapy / methods*
• Organoplatinum Compounds / administration & dosage
• Organoplatinum Compounds / adverse effects
• Oxaliplatin
• Pancreatic Neoplasms / drug therapy*
• Pancreatic Neoplasms / mortality